Did You Know...
...that the inventor of the electric motor was a blacksmith named Thomas Davenport? Described as "a brilliantly unsuccessful inventor", Davenport invented the first rotary electric motor. In 1836 he headed out -- on foot -- from his Vermont home to file a patent application at the Patent Office in Washington, D.C. By the time he got there, he had squandered away his money and couldn't afford the $30 filing fee so he turned around and went home. When he later mailed in his application with money he'd raised, the Patent office was destroyed in a fire. He did finally get credit for his invention on Feb. 5, 1837.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8184714 | Digital video codec using small-sized buffer memory Techniques, systems and apparatus for digital information processing are described. In particular, techniques, systems and apparatus are described for reducing the size of buffer memory used. In one aspect, a digital video codec includes a buffer memory including an... | 05/22/2012 |
| 8177899 | Non-aqueous pigment ink A non-aqueous pigment ink comprising a pigment, a pigment dispersant and a non-aqueous solvent, wherein the non-aqueous solvent comprises an alcohol solvent, a fatty acid ester solvent and a hydrocarbon solvent, the alcohol solvent comprises a saturated branched alc... | 05/15/2012 |
| 8176935 | Vapor recovery control valve A fuel vapor control valve comprising a housing fitted with an inlet port connectable to a fuel tank and an outlet port connectable to a fuel vapor recovery device. The inlet port and the outlet port are in flow communication via a first valve controlled passage adm... | 05/15/2012 |
| 8173599 | Spray-dried collectin compositions and process for preparing the same The present invention relates to a spray-dried composition comprising as an active ingredient at least one member protein of the collectin family or its functional equivalent for treating and preventing microbial infectious diseases. The present invention also relat... | 05/08/2012 |
| 8158109 | Foamable suspension gel The present subject matter provides foamable suspension gels that foam after release from a container. The foamable suspension gels contain at least one pharmaceutically active agent that is sparingly soluble to insoluble in water, a second pharmaceutically active a... | 04/17/2012 |
| 8153780 | Reporter unit for detection of target molecules using polymerisable substrate The invention relates to a reporter unit for detecting a target molecule comprising at least one component attached to a target molecule specific probe, wherein said at least one component is liberated from said probe by the activity of a first enzyme thereby making... | 04/10/2012 |
| 8149962 | Estimating frequency shift Techniques, systems and apparatus are described for estimating a frequency shift. An apparatus for estimating a frequency shift includes a fast Fourier transform unit to transform a signal of a time domain into a frequency domain and output fast Fourier transform sy... | 04/03/2012 |
| 8147852 | Modified azole compounds as antifungal and antibacterial agents The present invention relates to the compounds of formula (I), their preparation and use as antifungal and/or antibacterial agents. where the values for R1, R2, R3, R4, R5 | 04/03/2012 |
| 8137986 | Non-liquid phase type chemiluminescent enzyme immunoassay method and assay kit A chemiluminescent enzyme immunoassay method whereby a target substance such as a protein is assayed. This chemiluminescent enzyme immunoassay method comprises: the step of capturing an immune complex containing an enzyme-labeled antibody, which is labeled with an e... | 03/20/2012 |
| 8137395 | Vessel prosthesis, particularly for the replacement of aorta segments near the heart The invention relates to a vessel prosthesis, particularly for the replacement of aorta segments near the heart, in the form of a pleated flexible tube with folds (3), the tube being configured as an arc, and the arc shape being fixed in an extension-resistan... | 03/20/2012 |
| 8128745 | Emulsion ink and method for producing same An emulsion ink capable of generating a printed image quality having favorable print density and a favorable matte finish. A water-in-oil emulsion ink having an oil phase and a water phase, wherein the ink has a first water phase comprising a colorant and a second w... | 03/06/2012 |
| 8125528 | Apparatus for digital image stabilization, method using the same and computer readable medium stored thereon computer executable instructions for performing the method An apparatus for digital image stabilization according to the present invention comprises an image signal processing module for receiving image signals generated under first and second exposure value conditions (first exposure value condition>second exposure value c... | 02/28/2012 |
| D653859 | Synthetic resin paper | 02/14/2012 |
| 8106017 | Peptides for promoting hair growth and improving wrinkle and cosmetic compositions comprising the same The present invention relates to a peptide comprising a specific amino acid sequence possessing human thymosin β-4 (Tβ4) activities and its uses. The peptide of this invention has identical or similar functions or actions to human Tβ4 and its biological activity ... | 01/31/2012 |
| 8099656 | Reed solomon decoder Techniques, systems and computer program products are described for providing a Reed Solomon decoder. The Reed Solomon decoder includes a syndrome polynomial generator to generate syndrome polynomials for subchannel data received from subchannels. In addition, a syn... | 01/17/2012 |
| 8090458 | Method of calculating temporal information of frame-based audio stream data The present invention relates to a method of calculating temporal information of frame-based audio stream data, and more particularly, to a method of calculating temporal information of frame-based audio stream data, in which it can calculate time related informatio... | 01/03/2012 |
| 8089379 | Variable length decoding apparatus and method Techniques, apparatus and systems are described for performing variable length decoding. In one aspect, a variable length decoding apparatus includes a first computation unit to determine whether a symbol corresponding to an input data is included in an upper group ... | 01/03/2012 |
| 8088356 | Metal cation-doped covalent organic framework derivatives for hydrogen storage and method of using the same Disclosed are a novel hydrogen storage material with enhanced hydrogen storage capacity prepared by doping an organic framework material with light metal cations, and a method of using the same for hydrogen storage. The present inventive material has at least one ph... | 01/03/2012 |
| 8071133 | Oral dosage forms of water insoluble drugs and methods of making the same A method of making an oral dosage form of a water insoluble drug such as Saquinavir or Cyclosporine or Paclitaxel is carried out by: (a) providing a single phase working Solution comprising or consisting essentially of an active agent, water, a water-soluble polymer... | 12/06/2011 |
| 8067242 | Method for methylmalonic acid detemination based on alkylative extraction associated to liquid chromatography coupled to mass spectrometry The present invention relates to the determination of the presence of methylmalonic acid in biologic samples including the steps of methylmalonic extraction from the sample; derivatization of methylmalonic acid and use of mass spectrometry with negative mode atmosph... | 11/29/2011 |
| 8062650 | Biologically inhibiting material a method of producing said material as well as the use of said material for inhibiting live cells Method for inhibiting live cells including eukaryotic and prokaryotic cells on an item utilized outside the human or animal body. The method includes the step of providing on the item a biologically inhibiting material including an anode material and a cathode mater... | 11/22/2011 |
| 8048017 | High-aspect-ratio microdevices and methods for transdermal delivery and sampling of active substances High-aspect-ratio microdevices comprising microneedles, microknives and microblades and their manufacturing methods are disclosed. These devices can be used for the delivery of therapeutic agents across the skin or other tissue barriers to allow chemical and biologi... | 11/01/2011 |
| 8043250 | High-aspect-ratio microdevices and methods for transdermal delivery and sampling of active substances A method of usign a high-aspect ratio microdevice for treating, preventing or ameliorating a medical condition is provided. ... | 10/25/2011 |
| 8038784 | Non-aqueous pigment ink and non-aqueous pigment ink set A non-aqueous pigment ink comprising a pigment, a pigment dispersant and a non-aqueous solvent, wherein the pigment dispersant comprises a copolymer of vinylpyrrolidone and an alkene of 10 to 40 carbon atoms. ... | 10/18/2011 |
| 8029811 | Stabilized pharmaceutical product Use of an adsorbent and a sealed package (e.g. an overwrap) to protect a pharmaceutical product in a solid state in the presence of a reducing sugar. ... | 10/04/2011 |
| 8026070 | Differential detection of multimeric and monomeric forms of multimer-forming polypeptides A method for differentially detecting a multimeric form from a monomeric form of a multimer-forming polypeptide in a biosample includes (a) contacting the biosample to a capturing antibody recognizing an epitope on the multimer-forming polypeptide to capture the mon... | 09/27/2011 |
| 8025872 | Osteogenic synthetic peptides, pharmaceutical compositions comprising the same, and medium containing the same Disclosed herein is an osteogenic synthetic peptide, derived from bone morphogenetic protein-7, consisting of a sequence of 15 amino acid residues. Provided are also a pharmaceutical composition and a medium composition comprising the same. Having remarkable activit... | 09/27/2011 |
| 8017633 | Roflumilast for the treatment of diabetes mellitus The invention relates to the use of Roflumilast and/or Roflumilast N-Oxide for the treatment of diabetes mellitus and accompanying disorders thereof. The invention additionally relates to combinations of Roflumilast and/or Roflumilast N-Oxide with other active agent... | 09/13/2011 |
| 8012727 | Biological production method of photoconductive arsenic-sulfide (As-S) nanotube and strain used for the same Disclosed is a biological method for preparing arsenic sulfide (As—S) compounds. More particularly, the present invention provides a method for production of nanotubes based on As—S compounds including As2S3 by reacting thiosulfate S2 | 09/06/2011 |
| 8008026 | Methods for differentially detecting a multimeric form from a monomeric form of a multimer-forming polypeptide through three-dimensional interactions The present invention relates to a method for differentially detecting a multimeric form from a monomeric form of a multimer-forming polypeptide in a biosample, which comprises the steps of: (a) preparing a carrier-capturing antibody conjugate by binding a capturing... | 08/30/2011 |
| 8003798 | Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors Compounds of the formula I in which the substituents have the definitions provided in the specification, are novel, effective PDE4 inhibitors. ... | 08/23/2011 |
| 7988999 | Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient The present invention relates to the field of pharmaceutical technology and describes a pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient, in particular an acid-labile proton pump inhibitor. The invention also relates to p... | 08/02/2011 |
| 7951398 | Pharmaceutical preparation comprising an active dispersed on a matrix The present invention relates to the field of pharmaceutical technology and describes a novel advantageous preparation for an active ingredient. The novel preparation is suitable for producing a large number of pharmaceutical dosage forms. In the new preparation, an... | 05/31/2011 |
| 7951396 | Preparation of nanoliposome-encapsulating proteins and protein-encapsulated nanoliposome Preparing a nanoliposome for encapsulating a protein includes preparing a dispersion by dispersing a phospholipid in an aqueous solution containing the protein, applying a shearing force to the dispersion; adding an additional amount of the phospholipid to the resul... | 05/31/2011 |
| 7947744 | Stable pharmaceutical products Provided herein is a stable pharmaceutical product comprising a dry powder inhalation device, and a pharmaceutical composition that comprises R,R-Formoterol L-tartrate salt, in particular crystalline R,R-formoterol L-tartrate; and ciclesonide. ... | 05/24/2011 |
| 7939495 | Method for improving skin conditions Provided is a method for improving a skin condition or treating a periodontal disease, which includes administering to a subject a composition including a basic fibroblast growth factor-derived peptide as an active ingredient. The present method effectively improves... | 05/10/2011 |
| 7927864 | Methods, kits, and compositions for detecting enzyme activity The inventive subject matter relates to methods, kits, and compositions for detecting enzyme activity in a biological sample. In particular, the inventive subject matter relates to methods, kits, and compositions for detecting von Willebrand factor degrading enzyme ... | 04/19/2011 |
| 7927829 | Method for in vitro phosphorylation of trap of and a method for screening the inhibitor of the trap phosphorylation The present invention relates to a method for in vitro phosphorylation of TRAP derived from Staphylococcus aureus. In the present invention, the TRAP is first identified as a kinase that self-phosphorylates and is phosphorylated specifically in the presence o... | 04/19/2011 |
| 7915302 | Crystal forms of pyrrolylheptanoic acid derivatives The present invention provides novel crystalline forms D1 and D2 of [R—(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemicalcium salt, and hydrates thereof. The crystallin... | 03/29/2011 |
| 7879899 | Injectable veterinary composition for small animals An injectable aqueous composition for veterinary use containing a non-steroidal anti-inflammatory compound in an amount of from about 0.25 to 30% (w/v) together with a physiologically acceptable oxygenated polymeric surfactant in an amount of from about 0.5 to 20% (... | 02/01/2011 |
